Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?
Postpartum Hemorrhage
About this trial
This is an interventional prevention trial for Postpartum Hemorrhage focused on measuring Oxytocin, bolus, postpartum hemorrhage
Eligibility Criteria
Inclusion Criteria: Aged 19 years or over Having a cesarean section Have one or more of the following a larger than average uterus, because of a large baby twins, triplets, etc a large volume of fluid around the baby have received oxytocin to help stimulate labor for eight or more hours before cesarean section have infection inside the uterus that is treated with antibiotics bleeding after giving prior birth the placenta is in a position where it is more likely to bleed have had five or more pregnancies before current one Exclusion Criteria: Significant medical problem such that an oxytocin bolus might not be safe Active bleeding and their blood pressure or pulse rate are not normal Blood does not clot normally Aged less than 19 years Does not understand English
Sites / Locations
- BC Women's Hospital, Department of Anesthesia
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
1
2
In the other group, the women will receive a small injection of oxytocin directly into the vein via their intravenous (bolus) after their baby is born.
In one group, women will receive a small injection of saline (salt water) directly into the vein via their intravenous (bolus) after their baby is born.